Canada’s regulatory approach to drugs for rare diseases: orphan drugs (French, HTML)
View metadata and access the original French HTML file: Canada’s regulatory approach to drugs for rare diseases: orphan drugs.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2023-12-02
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file